Answer
Steglatro (ertugliflozin) is not recommended for people with severe hepatic impairment because it has not been studied in these patients.
Sources for this answer
- Steglatro 5 mg and 15 mg film-coated tabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.2 Posology and method of administration · Version 9Document updated
Sources checked